Strides Pharma Science Completes 100% Acquisition of Neviton Softech for €2 Million, Subsidiary Arco Lab Buys Remaining 50%

Strides Pharma Science Limited on Tuesday informed exchanges that its wholly owned subsidiary, Arco Lab Private Limited, has completed the acquisition of the remaining 50% equity stake in Neviton Softech Private Limited for a cash consideration of €2 million (approximately ₹21.77 crore).

The transaction was completed on February 16, 2026, resulting in Neviton becoming a wholly owned subsidiary of Arco Lab and a step-down subsidiary of Strides.

The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Transaction Details and Consideration

Arco Lab acquired 5,560 equity shares, representing the remaining 50% paid-up equity share capital of Neviton, from Universal Alloy Corporation Design S.R.L (UACD), a Romanian company.

Arco Lab had previously acquired a 25% stake in Neviton in August 2022 and an additional 25% in January 2024. With the latest transaction, it now holds 100% ownership.

The consideration for the acquisition was paid in cash. The company stated that no governmental or regulatory approvals were required for the transaction and that completion was immediate.

Financial Profile of Neviton Softech

Neviton Softech operates in the Information Technology and Engineering Services segment, providing IT services and engineering solutions to a broad range of businesses. Its capabilities include developing machine interfaces through IoT devices and integrating live data feeds into real-time applications.

For FY25, Neviton reported:

• Turnover of ₹27.08 crore
• Profit After Tax of ₹4.26 crore
• Net worth of ₹25.20 crore

Its turnover for the previous three financial years stood at approximately ₹28.19 crore in FY24 and ₹24.48 crore in FY23.

Neviton was incorporated on February 25, 2010, and has operations in India and the United States.

Rationale and Strategic Context

Arco Lab, established as a global life science capability centre for Strides, provides IT infrastructure, enterprise application services, manufacturing IT services, new technologies and cybersecurity services.

According to the company’s disclosure, the acquisition is intended to strengthen knowledge-based and IT service capabilities, enhance scale and support group-wide digitisation initiatives. The company stated that the transaction is complementary to Arco Lab’s existing business objectives.

From Arco Lab’s perspective, the acquisition is categorised as a related party transaction as the remaining stake was acquired from the other shareholder of Neviton. However, Strides clarified that none of its promoters or promoter group entities have any interest in the proposed transaction.

Source: https://nsearchives.nseindia.com/corporate/STRIDES_532531_17022026153550_SEIntimation_Neviton_acq_Signed.pdf